SOURCE: TheSUBWAY.com

November 13, 2007 10:45 ET

Early Alert Small Cap Trade Opportunity for Tuesday, November 13, 2007: RHGP Rated Outperform, Seven Dollar Price Target By Beacon!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL--(Marketwire - November 13, 2007) - TheSUBWAY.com announces the following stocks to its Action List: Renhuang Pharmaceuticals, Inc. (OTCBB: RHGP), Oracle (NASDAQ: ORCL), RemoteMDx, Inc. (OTCBB: RMDX), Unico, Incorporated (OTCBB: UCOI).

Renhuang Pharmaceuticals (OTCBB: RHGP) has been rated Outperform with a price target of $7.00 by Beacon Equity Research Analyst, Lisa Springer, CFA.

In the report, the analyst writes, "Renhuang has established a multi-channel research and development infrastructure consisting of in-house researchers, a post-doctoral working center, and collaborations with leading institutions and scientists. The Company has a portfolio of over 100 products, and a presence in more than 50 markets. It has a dominant share of the market for Acanthopanax-based natural medicines and controls 70% of China's Acanthopanax resource (also known as Siberian Ginseng). Products are distributed through a network of over 2,000 sales agents in 24 districts covering over 50% of China and also exported to Russia and Southeast Asia."

The full report is available at http://www.BeaconEquityResearch.com. Anyone interested in receiving alerts regarding Renhuang Pharmaceuticals research should email members@beaconequityresearch.com with "RHGP" in the subject line.

Other stocks highlighted include Oracle (NASDAQ: ORCL): Hot Stocks List, up 1% on 55 million shares, RemoteMDx, Inc. (OTCBB: RMDX): Hot Stocks List, up 3% on .6 million shares, Unico, Incorporated (OTCBB: UCOI): Hot Stocks List, down 18% on 286 million shares.

TheSUBWAY.com's Daily Stock Updates:

TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com.

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRGP has been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has been compensated twenty thousand shares for RHGP, and expects to receive an additional twenty thousand shares in future installments. CRG was previously compensated fifty five thousand shares for RHGP, and has sold those shares. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site are operated under a license from Capital Research Group, Inc., TheSUBWAY.com Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's affiliates, officers, directors and employees intend to buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information